Next, we performed ROC curves analysis for BRD4 expression and patient outcome, the area under curve (AUC) was 61% in our cohort, which gave evidence for BRD4 to serve as a prognosis marker for GC (Fig. 1d). Here, BRD4 is linked to gastric cancer.